Sandbox:milan: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {| class="infobox" style="float:right;" |- | 30px|link=Dyspnea resident survival guide|| <br> || <br> | Dyspnea resident survival guide|'''Resid...")
 
No edit summary
Line 1: Line 1:
<div style="width: 80%;">
__NOTOC__
__NOTOC__
{| class="infobox" style="float:right;"
{| class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 100px; background: #A8A8A8; position: fixed; top: 250px; right: 21px; border-radius: 0 0 10px 10px;" cellpadding="0" cellspacing="0";
|-
|-
| [[File:Siren.gif|30px|link=Dyspnea resident survival guide]]|| <br> || <br>
! style="padding: 0 5px; font-size: 85%; background: #A8A8A8" align=center| {{fontcolor|#2B3B44|Bradycardia Resident Survival Guide Microchapters}}
| [[Dyspnea resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Bradycardia resident survival guide#Overview|Overview]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Bradycardia resident survival guide#Causes|Causes]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Bradycardia resident survival guide#FIRE: Focused Initial Rapid Evaluation|FIRE]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Bradycardia resident survival guide#Complete Diagnostic Approach|Diagnosis]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Bradycardia resident survival guide#Treatment|Treatment]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Bradycardia resident survival guide#Do's|Do's]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Bradycardia resident survival guide#Don'ts|Don'ts]]
|}
|}
'''For patient information, click [[Dyspnea (patient information)|here]]'''
{{Dyspnea}}
{{CMG}}


==[[Dyspnea overview|Overview]]==
{{CMG}}: {{AE}} {{Ochuko}}; {{VB}}


==[[Dyspnea historical perspective|Historical Perspective]]==
==Overview==
Bradycardia is defined as a [[sinus rhythm]] with a rate < 60 beats per minute.  A heart rate of < 50 beats per minute is used as a working definition of bradycardia causing symptoms.<ref name="Neumar-2010">{{Cite journal  | last1 = Neumar | first1 = RW. | last2 = Otto | first2 = CW. | last3 = Link | first3 = MS. | last4 = Kronick | first4 = SL. | last5 = Shuster | first5 = M. | last6 = Callaway | first6 = CW. | last7 = Kudenchuk | first7 = PJ. | last8 = Ornato | first8 = JP. | last9 = McNally | first9 = B. | title = Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. | journal = Circulation | volume = 122 | issue = 18 Suppl 3 | pages = S729-67 | month = Nov | year = 2010 | doi = 10.1161/CIRCULATIONAHA.110.970988 | PMID = 20956224 }}</ref>  The evaluation of bradycardia includes assessment of heart rhythm, symptoms and associated medical conditions. The management of symptomatic bradycardia typically involves treating the underlying causes, the use of medications (e.g. [[atropine]]) or insertion of temporary or permanent [[pacemaker]].  Nevertheless, some asymtomatic bradycardias may require treatment to prevent complications.


==[[Dyspnea pathophysiology|Pathophysiology]]==
==Causes==


==[[Dyspnea causes|Causes]]==
===Life Threatening Causes===
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
*[[Hyperkalemia]]
*[[Hypoxemia]]
*[[Myocardial infarction|Inferior myocardial infarction]]
*[[Intracranial hypertension]]


==[[Dyspnea differential diagnosis|Differentiating Dyspnea from other Diseases]]==
===Common Causes===


==[[Dyspnea epidemiology and demographics|Epidemiology and Demographics]]==
*[[Carotid sinus hypersensitivity]]
* [[Medication]]s <div class="mw-collapsible-content">
<div class="mw-collapsible mw-collapsed">
: [[Amiodarone]]
: [[Amitriptyline]]
: [[Beta-blockers]]
: [[Cardiac glycosides]]
: [[Clonidine]]
: [[Diltiazem]]
: [[Dronedarone]]
: [[Flecainide]]
: [[Lithium]]
: [[Methyldopa]]
: [[Phenothiazines]]
: [[Procainamide]]
: [[Propafenone]]
: [[Quinidine]]
: [[Reserpine]]
: [[Verapamil]]
</div></div>
*[[Sick sinus syndrome]]


==[[Dyspnea risk factors|Risk Factors]]==
Click '''[[Bradycardia causes|here]]''' for the complete list of causes.


==[[Dyspnea natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==FIRE: Focused Initial Rapid Evaluation==
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.  The initial rapid evaluation is based on the 2005 AHA guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.<ref>{{cite journal|title=Part 7.3: Management of Symptomatic Bradycardia and Tachycardia|journal=Circulation|volume=112|issue=24_suppl|year=2005|pages=IV-67–IV-77|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.105.166558}}</ref>
<br>
<span style="font-size:85%">Boxes in red signify that an urgent management is needed.</span>


==Diagnosis==
<span style="font-size:85%">'''Abbreviations:''' '''IV:''' [[Intravenous]]; '''ECG:''' [[Electrocardiogram]]</span>
[[Dyspnea history and symptoms|History and Symptoms ]] | [[ Dyspnea physical examination|Physical Examination]] | [[Dyspnea laboratory findings|Laboratory Findings]] | [[Dyspnea electrocardiogram|Electrocardiogram]] | [[Dyspnea chest x ray|Chest X Ray]] | [[Dyspnea CT|CT]] | [[Dyspnea echocardiography|Echocardiography]] | [[Dyspnea other imaging findings|Other Imaging Findings]] | [[Dyspnea other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
{{familytree/start}}
[[Dyspnea medical therapy|Medical Therapy]] | [[Dyspnea surgery |Surgery]] | [[Dyspnea primary prevention|Primary Prevention]] | [[Dyspnea secondary prevention|Secondary Prevention]] | [[Dyspnea cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Dyspnea future or investigational therapies|Future or Investigational Therapies]]
{{familytree | | | | | B01 | | | | | |B01=<div style="float: left; text-align: left; line-height: 150% ">'''Identify cardinal findings that increase the pretest probability of bradycardia''' <br> ❑ [[Heart rate]] < 50 beats/min </div>}}
{{familytree | | | | | |!| | | | | | | | }}
{{familytree | | | | | C01 | | | | | |C01=<div style="float: left; text-align: left; line-height: 150% ">'''Does the patient have any of the following findings of hemodyanamic instability that require urgent treatment?'''<br> ❑ [[Shock]] <br> ❑ [[Altered mental status]] <br> ❑ [[Hypotension]] <br> ❑ [[Hypothermia]] <br> ❑ [[Oliguria]] </div>}}
{{familytree | | | |,|-|^|-|.| }}
{{familytree | | | D01 | | D02| |D01=<div style=" width: 20em; background: #FA8072"> {{fontcolor|#F8F8FF|'''Yes'''}}</div>|D02='''No'''}}
{{familytree | | | |!| | | |!| }}
{{familytree | | | |!| | | E02 |E02=<div style="float: left; text-align: left; width: 20em; padding:1em;">  '''[[Bradycardia resident survival guide#Complete Diagnostic Approach|Continue with the complete diagnostic approach below]]''' </div>}}
{{familytree | | | E01 | | | | | | | | | | | | | | | | | | |E01=<div style="float: left; text-align: left; line-height: 150%; width: 20em; background: #FA8072"> {{fontcolor|#F8F8FF|'''Initial Stabilization'''<br> ''Do the following simultaneously without delaying the treatment''<br><br>❑ Maintain patent airway <br> ❑ Assist breathing if required <br> ❑ Place patient on cardiac monitor <br> ❑ Give supplemental oxygen <br> ❑ Monitor blood pressure and evaluate oxyhemoglobin saturation <br> ❑ Establish IV access <br> ❑ Obtain [[ECG|<span style="color:white;">ECG</span>]] to define rhythm <br> ❑ Evaluate clinical status and identify reversible causes simultaneously}}</div>}}
{{familytree | | | |!| | | | | |}}
{{familytree | | | P01 | | | | | P01=<div style=" width: 20em; background: #FA8072"> {{fontcolor|#F8F8FF|Is there an [[AV block|<span style="color:white;">AV block</span>]]?}}</div>}}
{{familytree | | |,|^|-|-|-|.| | | | }}
{{familytree | | V01 | | | V02 | | | | |V01=<div style=" width: 20em; background: #FA8072"> {{fontcolor|#F8F8FF|'''No'''}}</div>|V02=<div style=" width: 20em; background: #FA8072"> {{fontcolor|#F8F8FF|'''Yes'''}}</div>}}
{{familytree | | |!| | |,|-|^|-|.| | | | | | | | | | |}}
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | | |!| | F01 | | F02 | | F01= [[Second degree AV block]]/[[Third-degree AV block]]| F02= [[First degree AV block|<span style="color:white;">First degree AV block</span>]]}}
{{familytree | | |!| | |!| | | |!| | | }}
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | G01 | | G02 | | G03 | | | | | | | | | | |G01=<div style="float: left; text-align: left; width: 20em; line-height: 150%; background: #FA8072"> {{fontcolor|#F8F8FF|'''First Line Treatment Option'''<br> ❑ Administer atropine 0.5 mg IV bolus and repeat every 3-5 mins with a maximum dose of 3 mg <br><br> '''Second Line Treatment Options''' <br>
❑ Administer [[dopamine|<span style="color:white;">Dopamine</span>]] infusion (2-10 mcg/kg/min) <br> OR <br>
❑ Administer [[epinephrine|<span style="color:white;">Epinephrine</span>]] infusion (2-10 mcg/min) <br> OR <br>
❑ Proceed with [[transcutaneous pacing|<span style="color:white;">transcutaneous pacing</span>]] <br> ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]]) }}</div>|G02=<div style="float: left; text-align: left; line-height: 150%; width: 20em; background: #FA8072"> {{fontcolor|#F8F8FF| '''DO NOT GIVE ATROPINE''' <br> ❑ Proceed with [[transcutaneous pacing|<span style="color:white;">transcutaneous pacing</span>]]}}</div> |G03=<div style="float: left; text-align: left; width: 20em; line-height: 150%; background: #FA8072"> {{fontcolor|#F8F8FF|'''First Line Treatment Option'''<br> ❑ Administer atropine 0.5 mg IV bolus and repeat every 3-5 mins with a maximum dose of 3 mg <br><br> '''Second Line Treatment Options''' <br>
❑ Administer [[dopamine|<span style="color:white;">Dopamine</span>]] infusion (2-10 mcg/kg/min) <br> OR <br>
❑ Administer [[epinephrine|<span style="color:white;">Epinephrine</span>]] infusion (2-10 mcg/min) <br> OR <br>
❑ Proceed with [[transcutaneous pacing|<span style="color:white;">transcutaneous pacing</span>]] <br> ([[ACC AHA guidelines classification scheme|Class IIa, level of evidence B]]) }} </div>}}
{{familytree | | |`|-|v|-|'| | | | | | | | | | | | | | | |}}
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | | | | H01 | | | | | | | | | |H01=<div style="float: left; text-align: left; line-height: 150%; width: 20em; background: #FA8072"> {{fontcolor|#F8F8FF|'''Are the signs of poor perfusion or shock persisting?'''}} </div>}}
{{familytree | | |,|-|^|-|.| | }}
{{familytree | | I01 | | I02 | I01= Yes| I02= No}}
{{familytree | | |!| | | |!| | }}
{{familytree | | J01 | | J02 | J01= ❑ Consult a cardiologist and <br>❑ Prepare patient for [[transvenous pacing|<span style="color:white;">transvenous pacing</span>]]| J02= <div style="float: left; text-align: left; width: 20em; padding:1em;">  '''[[Bradycardia resident survival guide#Complete Diagnostic Approach|Continue with the complete diagnostic approach below]]''' </div>}}
{{familytree/end}}
<br>
 
==Complete Diagnostic Approach==
A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.<ref name="Neumar-2010">{{Cite journal  | last1 = Neumar | first1 = RW. | last2 = Otto | first2 = CW. | last3 = Link | first3 = MS. | last4 = Kronick | first4 = SL. | last5 = Shuster | first5 = M. | last6 = Callaway | first6 = CW. | last7 = Kudenchuk | first7 = PJ. | last8 = Ornato | first8 = JP. | last9 = McNally | first9 = B. | title = Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. | journal = Circulation | volume = 122 | issue = 18 Suppl 3 | pages = S729-67 | month = Nov | year = 2010 | doi = 10.1161/CIRCULATIONAHA.110.970988 | PMID = 20956224 }}</ref><ref>{{cite journal|title=Part 7.3: Management of Symptomatic Bradycardia and Tachycardia|journal=Circulation|volume=112|issue=24_suppl|year=2005|pages=IV-67–IV-77|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.105.166558}}</ref>
 
<span style="font-size:85%">'''Abbreviations:''' '''CK-MB:''' [[Creatine kinase myocardial type]]; '''ECG:''' [[Electrocardiogram]]; '''TSH:''' [[Thyroid stimulating hormone]]</span>
 
{{Family tree/start}}
{{family tree | | | | V01 | |V01=  <div style="float: left; text-align: left; line-height: 150%; width: 35em">'''Characterize the symptoms:''' <br>
❑ [[Lightheadedness]] or [[dizziness]] <br> ❑ [[Dyspnea]] <br> ❑ [[Chest pain]] <br> ❑ [[Altered mental status]] <br>
❑ [[Syncope]] <br> ❑ [[Fatigue]] <br> ❑ [[Exercise intolerance]]<br>
'''Obtain a detailed history''': <br>
❑ [[Age]] (bradycardia is commonly seen in the elderly) <br>
❑ Use of negative chronotropic medications <br>
:❑ [[Beta blockers]]
:❑ [[Calcium channel blockers]]
:❑ [[Digoxin]] <br>
❑ Past medical history <br>
:❑ [[Sinus node disease|Disease in the sinus node]]
:❑ [[atrioventricular block|AV nodal disease]]
:❑ Age-related fibrosis and sclerosis
:❑ [[Infection]]
:❑ [[Increased intracranial pressure]]
:❑ [[Electrolyte disturbance]]
:❑ [[Toxin|Exposure to toxins]]
:❑ [[Surgery]]
:❑ [[Heart transplant]]
:❑ [[Sleep apnea]]
:❑ [[Myocardial infarction]]
:❑ [[Hypothyroidism]]</div>}}
{{family tree | | | | |!| | }}
{{Family tree | | | | A01 | |A01=<div style="float: left; text-align: left; width: 20em; padding:1em; width: 35em"> '''Examine the patient:'''<br>
'''Vitals'''<br>
❑ [[Pulse]] <br>
:❑ Rate <br> 
::❑ [[Heart rate]] < 60/min <br>
:❑ Rhythm <br>
::❑ Slow regular <br>
::❑ Irregular pulse of varying intensity (suggestive of the 2nd and 3rd degrees of [[AV block]]) <br>
❑ [[Respiration]] <br>
:❑ [[Tachypnea]] <br>
❑ [[Blood pressure]]<br>
:❑ [[Hypotension]] in some cases <br>
'''Skin'''<br>
❑ Inspection <br>
:❑ Dry or coarse skin <br>
:❑ Dry or coarse hair <br>
:❑ [[Pallor]] <br>
:❑ Facial edema (not common) <br>
❑ Palpation <br>
:❑ Cool lower extremities (due to poor [[cardiac output]]) <br>
'''Neck'''<br>
:❑ [[Jugular venous distension]] (suggestive of [[heart failure]]) <br>
:❑ [[Cannon a waves]] in [[jugular venous pulse]] (suggestive of [[complete heart block]]) <br>
'''Respiratory examination'''<br>
❑ Assessment of respiratory effort movement <br>
:❑ Intercostal retractions <br>
:❑ Suprasternal retractions <br>
❑ Auscultation <br>
:❑ [[Rales]] (uncommon) <br>
'''Cardiovascular examination'''<br>
❑ Auscultation <br>
:❑ [[Heart sounds]]
::❑ [[Heart sounds#Third heart sound S3|S3]] (uncommon) <br> 
'''Abdominal examination'''<br>
❑ Percussion<br>
:❑ [[Ascites]] - suggestive of [[heart failure]] (uncommon)<br>
'''Extremities'''<br>
❑ Inspection/palpation <br>
:❑ Lower extremity edema - suggestive of [[heart failure]] (uncommon)</div>}}
{{Family tree | | | | |!| | }}
{{family tree | | | | P01 | |P01=<div style="float: left; text-align: left; line-height: 150%; width: 35em">'''Consider alternative diagnosses''':<br> ❑ [[Ventricular bigeminy]] <br> ❑ [[premature ventricular contraction|Frequent premature ventricular contractions (PVCs)]] <br> ❑ [[Atrial fibrillation]] <br> ❑ [[premature atrial contraction|Blocked premature atrial contractions (PACs)]] <br> ❑ [[Cardiac tamponade]] </div>}}
{{Family tree | | | | |!| | | }}
{{family tree | | | | R01 | |R01=<div style="float: left; text-align: left; line-height: 150%; width: 35em">'''Order tests''':<br> '''First initial test''' <br>
❑ [[ECG|12-lead ECG]] (to determine rhythm)


==Case Studies==
[[Image:Sinusbradycardia.png|300px|center|thumb|12-lead [[ECG]] showing sinus bradycardia]]<br>
'''Other initial tests''' <br>
❑ [[Holter monitoring]]- to evaluate <br>
:❑ Severe [[sinus bradycardia]] <br>
:❑ Sinus pauses <br>
:❑ Sinus arrest <br>
:❑  Second-or third-degree [[AV block]] <br>
❑ [[Exercise stress testing]] (for diagnoses of [[sick sinus syndrome]] and [[ischemic heart disease]]) <br>
❑ [[Carotid sinus massage]] (to evaluate [[carotid sinus hypersensitivity]]) <br>
❑ [[Echocardiogram]] (to evaluate [[valvular heart disease]]) <br>
'''Laboratory tests''' <br>
❑ [[Thyroid function tests]] (elevated [[TSH]] in [[hypothyroidism]]) <br>
❑ [[Basic metabolic panel]] (to determine [[electrolyte disturbances]]) <br>
❑ [[Cardiac enzymes]] ([[creatine kinase]], [[CK-MB]] and [[troponin]]) <br>
❑ [[creatinine|Serum creatinine]] (elevated in renal impairment) <br>
❑ Serum digoxin (for junctional bradycardia)<br>
'''Other Investigations''' <br>
❑ [[Tilt-table testing]] (to evaluate autonomic system and diagnosis of [[neurocardiogenic syncope]]) <br>
❑ [[Electrophysiologic testing]] (to evaluate [[bradyarrhythmias]])</div>}}
{{family tree/end}}


[[Dyspnea case study one|Case #1]]
==Treatment==
Shown below is an algorithm depicting the treatment of bradycardia based on the 2010 AHA guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.<ref name="Neumar-2010">{{Cite journal  | last1 = Neumar | first1 = RW. | last2 = Otto | first2 = CW. | last3 = Link | first3 = MS. | last4 = Kronick | first4 = SL. | last5 = Shuster | first5 = M. | last6 = Callaway | first6 = CW. | last7 = Kudenchuk | first7 = PJ. | last8 = Ornato | first8 = JP. | last9 = McNally | first9 = B. | title = Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. | journal = Circulation | volume = 122 | issue = 18 Suppl 3 | pages = S729-67 | month = Nov | year = 2010 | doi = 10.1161/CIRCULATIONAHA.110.970988 | PMID = 20956224 }}</ref>


== Related Chapters ==
{{family tree/start}}
{{family tree | | | | A01 | | | |A01=[[Bradycardia]]/[[Bradyarrhythmia]] with [[heart rate]] <br> < 60/min}}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | B01 | | | |B01=<div style="float: left; text-align: left; line-height: 150% ">'''Identify underlying causes:'''<br>
❑ [[Acidosis]]<br>
❑ [[Carotid sinus hypersensitivity]]<br>
❑ [[Electrolyte imbalance]] e.g. [[Hyperkalemia]]<br>
❑ [[Hypoglycemia]]<br>
❑ [[Hypothermia]]<br>
❑ [[Hypoxemia]]<br>
❑ [[Sick sinus syndrome]]<br>
❑ [[Toxins]]<br>
</div>}}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | C01 | | | |C01=<div style="float: left; text-align: left; line-height: 150% "> '''Determine signs and symptoms of hemodynamic instability''' <br> ❑ [[Hypotension]] <br> ❑ Acutely altered mental status <br> ❑ Signs of [[shock]] <br> ❑ [[Ischemia|Ischemic]] chest discomfort <br> ❑  Acute [[heart failure]]</div>}}
{{Family tree | |,|-|-|^|-|-|.| | }}
{{Family tree | D01 | | | | D02 |D01= '''Unstable'''| D02= '''Stable'''}}
{{family tree | |!| | | | | |!| |}}
{{family tree | X01 | | | | X02 | |X01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''<br>
'''[[Bradycardia resident survival guide#Focused Initial Rapid Evaluation|Continue with focused initial rapid evaluation above]]''' </div>|X02=<div style="float: left; text-align: left; line-height: 150% "> <br> ❑ Close follow up and monitoring <br> ❑ Identify and treat underlying causes</div>}}
{{family tree | |,|-|-|-|v|-|^|-|v|-|-|-|.| |}}
{{family tree | Y01 | | Y02 | | Y03 | | Y04 | |Y01=<div style="float: left; text-align: left; line-height: 150% ">'''[[Sinus node dysfunction]]''' <br>
❑ Treat underlying cause <br>
:❑ Withdrawal of [[medication]] <br>
:❑ Administer electrolytes to correct for imbalance <br> 
:❑ Correction of thyroid dysfunction <br>
:❑ Correction of [[hypoglycemia]] <br>
❑ Give [[Theophylline]] 200-400mg PO twice daily for [[fatigue]] and/or [[dizziness]] <br> ❑ [[artificial pacemaker|Temporary pacing]] for severe symptoms <br> ❑ [[artificial pacemaker|Permanent pacing]] for irreversible causes with severe symptoms (e.g. [[Sinus node dysfunction]] with [[AV block]] or [[Afib]]</div>|Y02=<div style="float: left; text-align: left; line-height: 150% ">'''[[AV Block]]''' <br> '''Acquired or Congenital''' <br> ❑  Treat underlying cause <br> ❑  [[artificial pacemaker|Temporary pacing]] if indicated <br> ❑ Reassurance for irreversible causes without indication for pacing <br> ❑ [[artificial pacemaker|Permanent pacing]] for symptomatic irreversible causes</div>|Y03= '''[[Carotid sinus hypersensitivity]]''' <br> [[artificial pacemaker|Permanent pacing]]|Y04=<div style="float: left; text-align: left; line-height: 150% ">'''[[Neurocardiogenic syncope]]''' <br>
❑ Lifestyle modification <br>
:❑ Adequate salt and fluid intake <br>
:❑ Elevation of legs, lying down and tensing maneuvers <br>
:❑ Avoid precipitating factors <br>
❑ [[Fludrocortisone]] 0.1-0.2mg PO once daily <br> OR <br>
❑ [[Midodrine]] 2.5-10mg PO tid <br> OR <br>
❑ [[Fluoxetine]] 20mg PO once daily <br> OR <br>
❑ [[artificial pacemaker|Permanent pacing]]</div>}}
{{Family tree/end}}


* [[Air hunger]]
==Do's==
* [[Bradypnea]]
* Prepare for transcutaneous pacing if perfusion is poor.
* [[Eupnea]]
* Consider using sodium bicarbonate for severe metabolic acidosis.
* [[Orthopnea]]
* Use atropine with caution in the presence of [[myocardial ischemia]] and [[acute coronary syndrome]] because it increases oxygen demand and could worsen the [[ischemia]] and increase infarction size.<ref name="Neumar-2010">{{Cite journal  | last1 = Neumar | first1 = RW. | last2 = Otto | first2 = CW. | last3 = Link | first3 = MS. | last4 = Kronick | first4 = SL. | last5 = Shuster | first5 = M. | last6 = Callaway | first6 = CW. | last7 = Kudenchuk | first7 = PJ. | last8 = Ornato | first8 = JP. | last9 = McNally | first9 = B. | title = Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. | journal = Circulation | volume = 122 | issue = 18 Suppl 3 | pages = S729-67 | month = Nov | year = 2010 | doi = 10.1161/CIRCULATIONAHA.110.970988 | PMID = 20956224 }}</ref>
* [[Paroxysmal nocturnal dyspnea]]
* Consider immediate pacing in unstable patients with high degree [[AV block]] when IV access isn't available.([[ACC AHA guidelines classification scheme|Class IIb, level of evidence C]])<ref name="Neumar-2010">{{Cite journal  | last1 = Neumar | first1 = RW. | last2 = Otto | first2 = CW. | last3 = Link | first3 = MS. | last4 = Kronick | first4 = SL. | last5 = Shuster | first5 = M. | last6 = Callaway | first6 = CW. | last7 = Kudenchuk | first7 = PJ. | last8 = Ornato | first8 = JP. | last9 = McNally | first9 = B. | title = Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. | journal = Circulation | volume = 122 | issue = 18 Suppl 3 | pages = S729-67 | month = Nov | year = 2010 | doi = 10.1161/CIRCULATIONAHA.110.970988 | PMID = 20956224 }}</ref>
* [[Tachypnea]]
* [[Trepopnea]]


[[ca:Dispnea]]
==Don'ts==
[[da:Åndenød]]
* Do not treat asymptomatic or minimally symptomatic patients, unless the rhythm is likely to progress to symptoms or become life threatening.<ref name="Neumar-2010">{{Cite journal  | last1 = Neumar | first1 = RW. | last2 = Otto | first2 = CW. | last3 = Link | first3 = MS. | last4 = Kronick | first4 = SL. | last5 = Shuster | first5 = M. | last6 = Callaway | first6 = CW. | last7 = Kudenchuk | first7 = PJ. | last8 = Ornato | first8 = JP. | last9 = McNally | first9 = B. | title = Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. | journal = Circulation | volume = 122 | issue = 18 Suppl 3 | pages = S729-67 | month = Nov | year = 2010 | doi = 10.1161/CIRCULATIONAHA.110.970988 | PMID = 20956224 }}</ref>
[[de:Dyspnoe]]
* Do not delay pacing if the rhythm is Mobitz type II second degree block or third-degree [[AV block]] even if the patient is asymptomatic.
[[es:Disnea]]
* Do not use atropine in hypothermic patients with either bradycardia or Mobitz type II second degree AV block.
[[eu:Arnasestu]]
* Do not use [[atropine]] to treat bradycardia in [[cardiac transplant]] patients as the transplanted heart lacks vagal innervation.<ref name="Neumar-2010">{{Cite journal  | last1 = Neumar | first1 = RW. | last2 = Otto | first2 = CW. | last3 = Link | first3 = MS. | last4 = Kronick | first4 = SL. | last5 = Shuster | first5 = M. | last6 = Callaway | first6 = CW. | last7 = Kudenchuk | first7 = PJ. | last8 = Ornato | first8 = JP. | last9 = McNally | first9 = B. | title = Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. | journal = Circulation | volume = 122 | issue = 18 Suppl 3 | pages = S729-67 | month = Nov | year = 2010 | doi = 10.1161/CIRCULATIONAHA.110.970988 | PMID = 20956224 }}</ref>
[[fr:Dyspnée]]
* Do not use [[atropine]] to treat type II second degree and third degree [[heart block]]s since their management requires transcutaneous/[[transvenous pacing]].
[[it:Dispnea]]
[[nl:Benauwdheid]]
[[ja:呼吸困難]]
[[no:Dyspné]]
[[nn:Andenød]]
[[pt:Dispnéia]]
[[qu:Sasa samay]]
[[ru:Одышка]]
[[sk:Dyspnoe]]
[[sv:Dyspné]]
[[uk:Задишка]]
[[zh:呼吸困难]]


[[pl:Duszność]]
==References==
{{Reflist|2}}


[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Pulmonology]]
[[Category:Resident survival guide]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Symptoms]]
[[Category:Symptoms]]
[[Category:Signs and symptoms]]
[[Category:Emergency medicine]]
[[Category:primary care]]
[[Category:Arrhythmia]]
 
[[Category:Electrophysiology]]
{{WikiDoc Help Menu}}
[[Category:Up-To-Date]]
[[Category:Up-To-Date cardiology]]


{{WikiDoc Sources}}
{{WH}}
{{WS}}
</div>

Revision as of 00:59, 27 April 2014

Bradycardia Resident Survival Guide Microchapters
Overview
Causes
FIRE
Diagnosis
Treatment
Do's
Don'ts

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]; Vidit Bhargava, M.B.B.S [3]

Overview

Bradycardia is defined as a sinus rhythm with a rate < 60 beats per minute. A heart rate of < 50 beats per minute is used as a working definition of bradycardia causing symptoms.[1] The evaluation of bradycardia includes assessment of heart rhythm, symptoms and associated medical conditions. The management of symptomatic bradycardia typically involves treating the underlying causes, the use of medications (e.g. atropine) or insertion of temporary or permanent pacemaker. Nevertheless, some asymtomatic bradycardias may require treatment to prevent complications.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Click here for the complete list of causes.

FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention. The initial rapid evaluation is based on the 2005 AHA guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.[2]
Boxes in red signify that an urgent management is needed.

Abbreviations: IV: Intravenous; ECG: Electrocardiogram

 
 
 
 
Identify cardinal findings that increase the pretest probability of bradycardia
Heart rate < 50 beats/min
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have any of the following findings of hemodyanamic instability that require urgent treatment?
Shock
Altered mental status
Hypotension
Hypothermia
Oliguria
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial Stabilization
Do the following simultaneously without delaying the treatment

❑ Maintain patent airway
❑ Assist breathing if required
❑ Place patient on cardiac monitor
❑ Give supplemental oxygen
❑ Monitor blood pressure and evaluate oxyhemoglobin saturation
❑ Establish IV access
❑ Obtain ECG to define rhythm
❑ Evaluate clinical status and identify reversible causes simultaneously
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is there an AV block?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
 
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Second degree AV block/Third-degree AV block
 
First degree AV block
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
First Line Treatment Option
❑ Administer atropine 0.5 mg IV bolus and repeat every 3-5 mins with a maximum dose of 3 mg

Second Line Treatment Options

❑ Administer Dopamine infusion (2-10 mcg/kg/min)
OR
❑ Administer Epinephrine infusion (2-10 mcg/min)
OR

❑ Proceed with transcutaneous pacing
(Class IIa, level of evidence B)
 
DO NOT GIVE ATROPINE
❑ Proceed with transcutaneous pacing
 
First Line Treatment Option
❑ Administer atropine 0.5 mg IV bolus and repeat every 3-5 mins with a maximum dose of 3 mg

Second Line Treatment Options

❑ Administer Dopamine infusion (2-10 mcg/kg/min)
OR
❑ Administer Epinephrine infusion (2-10 mcg/min)
OR

❑ Proceed with transcutaneous pacing
(Class IIa, level of evidence B)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Are the signs of poor perfusion or shock persisting?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
 
 
 
 
 
 
 
 
 
 
 
❑ Consult a cardiologist and
❑ Prepare patient for transvenous pacing
 


Complete Diagnostic Approach

A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.[1][3]

Abbreviations: CK-MB: Creatine kinase myocardial type; ECG: Electrocardiogram; TSH: Thyroid stimulating hormone

 
 
 
Characterize the symptoms:

Lightheadedness or dizziness
Dyspnea
Chest pain
Altered mental status
Syncope
Fatigue
Exercise intolerance
Obtain a detailed history:
Age (bradycardia is commonly seen in the elderly)
❑ Use of negative chronotropic medications

Beta blockers
Calcium channel blockers
Digoxin

❑ Past medical history

Disease in the sinus node
AV nodal disease
❑ Age-related fibrosis and sclerosis
Infection
Increased intracranial pressure
Electrolyte disturbance
Exposure to toxins
Surgery
Heart transplant
Sleep apnea
Myocardial infarction
Hypothyroidism
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:

Vitals
Pulse

❑ Rate
Heart rate < 60/min
❑ Rhythm
❑ Slow regular
❑ Irregular pulse of varying intensity (suggestive of the 2nd and 3rd degrees of AV block)

Respiration

Tachypnea

Blood pressure

Hypotension in some cases

Skin
❑ Inspection

❑ Dry or coarse skin
❑ Dry or coarse hair
Pallor
❑ Facial edema (not common)

❑ Palpation

❑ Cool lower extremities (due to poor cardiac output)

Neck

Jugular venous distension (suggestive of heart failure)
Cannon a waves in jugular venous pulse (suggestive of complete heart block)

Respiratory examination
❑ Assessment of respiratory effort movement

❑ Intercostal retractions
❑ Suprasternal retractions

❑ Auscultation

Rales (uncommon)

Cardiovascular examination
❑ Auscultation

Heart sounds
S3 (uncommon)

Abdominal examination
❑ Percussion

Ascites - suggestive of heart failure (uncommon)

Extremities
❑ Inspection/palpation

❑ Lower extremity edema - suggestive of heart failure (uncommon)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order tests:
First initial test

12-lead ECG (to determine rhythm)

12-lead ECG showing sinus bradycardia

Other initial tests
Holter monitoring- to evaluate

❑ Severe sinus bradycardia
❑ Sinus pauses
❑ Sinus arrest
❑ Second-or third-degree AV block

Exercise stress testing (for diagnoses of sick sinus syndrome and ischemic heart disease)
Carotid sinus massage (to evaluate carotid sinus hypersensitivity)
Echocardiogram (to evaluate valvular heart disease)
Laboratory tests
Thyroid function tests (elevated TSH in hypothyroidism)
Basic metabolic panel (to determine electrolyte disturbances)
Cardiac enzymes (creatine kinase, CK-MB and troponin)
Serum creatinine (elevated in renal impairment)
❑ Serum digoxin (for junctional bradycardia)
Other Investigations
Tilt-table testing (to evaluate autonomic system and diagnosis of neurocardiogenic syncope)

Electrophysiologic testing (to evaluate bradyarrhythmias)
 

Treatment

Shown below is an algorithm depicting the treatment of bradycardia based on the 2010 AHA guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.[1]

 
 
 
Bradycardia/Bradyarrhythmia with heart rate
< 60/min
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Determine signs and symptoms of hemodynamic instability
Hypotension
❑ Acutely altered mental status
❑ Signs of shock
Ischemic chest discomfort
❑ Acute heart failure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unstable
 
 
 
Stable
 
 
 
 
 
 
 
 
 
 
 
 
 
 

❑ Close follow up and monitoring
❑ Identify and treat underlying causes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sinus node dysfunction

❑ Treat underlying cause

❑ Withdrawal of medication
❑ Administer electrolytes to correct for imbalance
❑ Correction of thyroid dysfunction
❑ Correction of hypoglycemia
❑ Give Theophylline 200-400mg PO twice daily for fatigue and/or dizziness
Temporary pacing for severe symptoms
Permanent pacing for irreversible causes with severe symptoms (e.g. Sinus node dysfunction with AV block or Afib
 
AV Block
Acquired or Congenital
❑ Treat underlying cause
Temporary pacing if indicated
❑ Reassurance for irreversible causes without indication for pacing
Permanent pacing for symptomatic irreversible causes
 
Carotid sinus hypersensitivity
Permanent pacing
 
Neurocardiogenic syncope

❑ Lifestyle modification

❑ Adequate salt and fluid intake
❑ Elevation of legs, lying down and tensing maneuvers
❑ Avoid precipitating factors

Fludrocortisone 0.1-0.2mg PO once daily
OR
Midodrine 2.5-10mg PO tid
OR
Fluoxetine 20mg PO once daily
OR

Permanent pacing
 

Do's

Don'ts

  • Do not treat asymptomatic or minimally symptomatic patients, unless the rhythm is likely to progress to symptoms or become life threatening.[1]
  • Do not delay pacing if the rhythm is Mobitz type II second degree block or third-degree AV block even if the patient is asymptomatic.
  • Do not use atropine in hypothermic patients with either bradycardia or Mobitz type II second degree AV block.
  • Do not use atropine to treat bradycardia in cardiac transplant patients as the transplanted heart lacks vagal innervation.[1]
  • Do not use atropine to treat type II second degree and third degree heart blocks since their management requires transcutaneous/transvenous pacing.

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Neumar, RW.; Otto, CW.; Link, MS.; Kronick, SL.; Shuster, M.; Callaway, CW.; Kudenchuk, PJ.; Ornato, JP.; McNally, B. (2010). "Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". Circulation. 122 (18 Suppl 3): S729–67. doi:10.1161/CIRCULATIONAHA.110.970988. PMID 20956224. Unknown parameter |month= ignored (help)
  2. "Part 7.3: Management of Symptomatic Bradycardia and Tachycardia". Circulation. 112 (24_suppl): IV-67–IV-77. 2005. doi:10.1161/CIRCULATIONAHA.105.166558. ISSN 0009-7322.
  3. "Part 7.3: Management of Symptomatic Bradycardia and Tachycardia". Circulation. 112 (24_suppl): IV-67–IV-77. 2005. doi:10.1161/CIRCULATIONAHA.105.166558. ISSN 0009-7322.

Template:WH Template:WS